Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03620903
Title Efficacy of First Line B-RI for Treatment Naive Waldenstrom's Macroglobulinemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Christian Buske
Indications
Therapies
Age Groups: adult | senior
Covered Countries GRC | DEU


No variant requirements are available.